Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 10/20 | 0.47 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | P2RY11 | Q96G91 | 2/20 | 0.43 |
| ▸ | NT5E | P21589 | 2/20 | 0.42 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.42 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.42 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.42 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.42 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.42 |
| ▸ | GPR17 | Q13304 | 2/20 | 0.41 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.41 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.40 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21078488 | 0.89 | P2RY1 (0.56) | P2RY1P2RY2P2RY11P2RX3P2RX1 | |
| SCHEMBL16374050 | 0.86 | POLG (0.48) | P2RY1P2RY2P2RY11NT5EP2RY6 | |
| SCHEMBL15833360 | 0.86 | POLG (0.48) | P2RY1P2RY2P2RY11NT5EP2RY6 | |
| SCHEMBL21078491 | 0.83 | ADORA3 (0.53) | P2RY1P2RY2P2RY11P2RX3P2RX1 | |
| SCHEMBL15837276 | 0.83 | POLG (0.39) | P2RY1P2RY2P2RY11 | |
| SCHEMBL21078680 | 0.83 | CA5A (0.56) | P2RY1CA5AP2RY11NT5EP2RX3 | |
| SCHEMBL21078589 | 0.82 | NT5E (0.48) | CA5ANT5E | |
| SCHEMBL31228218 | 0.82 | NT5E (0.48) | CA5ANT5E | |
| SCHEMBL16575842 | 0.81 | POLG (0.41) | P2RY1P2RY2P2RY11NT5EP2RX3 | |
| SCHEMBL17972004 | 0.81 | POLG (0.41) | P2RY1P2RY2P2RY11NT5EP2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | claimed |
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | disclosed |